Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$10.00 – $14.87
5% from low
Exchange
OTC Link
ADRC
Borrow rate
186.96%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $344.53B | $425.27B | $456.41B | $521.05B | $552.15B | $596.57B | $584.51B | $559.50B |
| Cost of revenue | $313.30B | $387.74B | $416.09B | $477.00B | $504.71B | $548.06B | $540.25B | $519.40B |
| Gross profit | $31.23B | $37.53B | $40.32B | $44.05B | $47.43B | $48.51B | $44.26B | $40.09B |
| Gross margin | 9.1% | 8.8% | 8.8% | 8.5% | 8.6% | 8.1% | 7.6% | 7.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $15.40B | $16.14B | $17.76B | $19.71B | $20.60B | $20.21B | $16.19B | $16.21B |
| EBITDA | $16.67B | $20.32B | $22.62B | $24.68B | $26.25B | $26.90B | $20.17B | $20.38B |
| Net income | $9.40B | $10.62B | $7.19B | $7.76B | $8.53B | $9.05B | $7.05B | $6.96B |
| Net margin | 2.7% | 2.5% | 1.6% | 1.5% | 1.5% | 1.5% | 1.2% | 1.2% |
| EPS (diluted) | 15.80 | 17.85 | 11.55 | 12.45 | 13.65 | 14.50 | 11.30 | 11.10 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $590.6B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $622.5B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
SINOPHARM GRP CO UNSP/ADR
No one on the platform currently holds SHTDY.
No tracked institution reports a position in SHTDY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-24 | $0.5095 | 2026-09-08 |
| 2025-06-17 | $0.4697 | 2025-08-27 |
| 2024-06-18 | $0.6124 | 2024-08-28 |
No one on the platform has traded SHTDY yet.
| +0.00% |
| $5.4B |
| — |
| SSMXFSysmex Corporation | $8.85 | +0.00% | $5.5B | — |
| SSMXYSysmex Corporation | $9.02 | -1.58% | $5.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.4× earnings vs its 1.0× historical median P/E.
Fair value ≈ $27.72 · price $10.26 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.